Zacks: Analysts Expect U.S. Bancorp (NYSE:USB) Will Announce Quarterly Sales of $5.73 Billion

Wall Street brokerages expect U.S. Bancorp (NYSE:USB) to announce sales of $5.73 billion for the current quarter, Zacks reports. Six analysts have issued estimates for U.S. Bancorp’s earnings, with the lowest sales estimate coming in at $5.69 billion and the highest estimate coming in at $5.76 billion. U.S. Bancorp posted sales of $5.61 billion during the same quarter last year, which suggests a positive year over year growth rate of 2.1%. The business is expected to report its next earnings report before the market opens on Wednesday, July 17th.

On average, analysts expect that U.S. Bancorp will report full-year sales of $22.88 billion for the current financial year, with estimates ranging from $22.62 billion to $22.96 billion. For the next year, analysts expect that the company will post sales of $23.49 billion, with estimates ranging from $22.85 billion to $23.79 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow U.S. Bancorp.

U.S. Bancorp (NYSE:USB) last posted its earnings results on Wednesday, July 17th. The financial services provider reported $1.09 EPS for the quarter, topping the consensus estimate of $1.07 by $0.02. U.S. Bancorp had a net margin of 27.02% and a return on equity of 15.53%. The firm had revenue of $5.58 billion during the quarter, compared to analysts’ expectations of $5.73 billion. During the same quarter in the prior year, the firm earned $1.02 EPS. U.S. Bancorp’s quarterly revenue was down 1.1% on a year-over-year basis.

USB has been the subject of several recent analyst reports. JPMorgan Chase & Co. initiated coverage on shares of Pinduoduo in a research report on Tuesday, July 9th. They issued an “underweight” rating and a $20.48 target price for the company. Zacks Investment Research upgraded shares of GreenTree Hospitality Group from a “sell” rating to a “hold” rating in a research report on Monday, April 15th. Finally, Oppenheimer set a $15.00 target price on shares of Strongbridge Biopharma and gave the stock a “buy” rating in a research report on Tuesday, March 26th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $57.75.

NYSE USB traded up $1.18 on Friday, hitting $54.22. The stock had a trading volume of 8,357,569 shares, compared to its average volume of 5,962,674. U.S. Bancorp has a one year low of $43.14 and a one year high of $55.56. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.83 and a current ratio of 0.84. The stock has a market cap of $84.57 billion, a PE ratio of 13.22, a price-to-earnings-growth ratio of 1.78 and a beta of 1.06. The firm’s 50-day simple moving average is $52.49.

The business also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Stockholders of record on Friday, June 28th were issued a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 2.73%. The ex-dividend date of this dividend was Thursday, June 27th. U.S. Bancorp’s dividend payout ratio (DPR) is presently 36.10%.

U.S. Bancorp declared that its board has initiated a stock repurchase plan on Thursday, June 27th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

In other news, Vice Chairman Gillern Jeffry H. Von sold 4,669 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $53.14, for a total value of $248,110.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Leslie V. Godridge sold 12,564 shares of the stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $51.53, for a total transaction of $647,422.92. Following the completion of the transaction, the insider now owns 39,330 shares of the company’s stock, valued at $2,026,674.90. The disclosure for this sale can be found here. Insiders sold 37,233 shares of company stock valued at $1,907,734 over the last quarter. Insiders own 0.24% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Trustcore Financial Services LLC bought a new stake in U.S. Bancorp during the first quarter worth approximately $28,000. Executive Wealth Management LLC bought a new stake in U.S. Bancorp during the fourth quarter worth approximately $27,000. Catamount Wealth Management boosted its holdings in U.S. Bancorp by 525.0% during the first quarter. Catamount Wealth Management now owns 750 shares of the financial services provider’s stock worth $36,000 after buying an additional 630 shares in the last quarter. ERTS Wealth Advisors LLC bought a new stake in U.S. Bancorp during the fourth quarter worth approximately $36,000. Finally, New Potomac Partners LLC bought a new stake in U.S. Bancorp during the first quarter worth approximately $37,000. Institutional investors and hedge funds own 74.63% of the company’s stock.

About U.S. Bancorp

U.S. Bancorp, a financial services holding company, provides various financial services in the United States. It operates in five segments: Corporate and Commercial Banking, Consumer and Business Banking, Wealth Management and Investment Services, Payment Services, and Treasury and Corporate Support.

Recommended Story: The role of implied volatility with call option volume

Get a free copy of the Zacks research report on U.S. Bancorp (USB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for U.S. Bancorp (NYSE:USB)

Receive News & Ratings for U.S. Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.